| Members |
targetComponentId |
| Other specified complication of labor and delivery affecting fetus or newborn, NEC |
Fetal or neonatal effect of complication of labour and/or delivery |
| Other specified connection between lacrimal gland and nose |
Creation of anastomosis between lacrimal drainage system and nose (procedure) |
| Other specified connection of stomach to duodenum |
Anastomosis of stomach |
| Other specified diffuse disease of connective tissue, NEC |
Collagen disease |
| Other specified disease of sebaceous gland, NEC |
Disorder of sebaceous gland (disorder) |
| Other specified disorder of skin, NEC |
Disorder of skin (disorder) |
| Other specified disorder of sweat gland, NEC |
Disorder of sweat gland (disorder) |
| Other specified disorder of testicular dysfunction, NEC |
Disorder of endocrine testis |
| Other specified fistula involving female genital tract, NEC |
Fistula of the female genital organs |
| Other specified form of osteochondropathy, NEC |
Osteochondropathy |
| Other specified hemorrhage in early pregnancy, delivered, with or without antepartum condition |
Hemorrhage in early pregnancy, delivered |
| Other specified hemorrhage of fetus or newborn, NEC |
Fetal OR neonatal hemorrhage |
| Other specified infection of the breast and nipple, NEC, associated with childbirth |
Infection of the breast AND/OR nipple associated with childbirth |
| Other specified inflammation of prostate |
Prostatitis |
| Other specified leprosy |
Leprosy |
| Other specified lichen condition, NEC |
Lichen |
| Other specified maternal complication affecting fetus or newborn, NEC |
Fetal or neonatal effect of maternal complication of pregnancy (disorder) |
| Other specified meningococcal infection, NEC |
Meningococcal infectious disease |
| Other specified multiple gestation, NEC |
Multiple pregnancy |
| Other specified muscle disorder, NEC |
Disorder of muscle |
| Other specified neuroses or other mental disorders |
Mental disorder |
| Other specified obstetrical trauma, NEC |
Traumatic lesion during delivery |
| Other specified other repair of anterior abdominal wall |
Reconstruction of anterior abdominal wall |
| Other specified polyglandular dysfunction, NEC |
Polyglandular dysfunction |
| Other specified trauma to perineum and vulva during delivery, NEC |
Traumatic lesion during delivery |
| Other specified tuberculosis of the central nervous system |
Tuberculosis of central nervous system |
| Other specified tularemia |
Tularemia |
| Other specified urticaria, NEC |
Urticaria |
| Other specified viral hepatitis |
Viral hepatitis |
| Other specified viral hepatitis with hepatic coma |
Hepatic coma due to viral hepatitis (disorder) |
| Other specified viral hepatitis without mention of hepatic coma |
Viral hepatitis without hepatic coma |
| Other specified wound of ocular adnexa, NEC |
Wound of ocular adnexa |
| Other syndrome of diencephalo-hypophyseal origin |
Syndrome of diencephalo-hypophyseal origin |
| Other testicular hypofunction, NEC |
Testicular hypofunction |
| Other thalamic nuclei, NEC |
Thalamic structure |
| Other tick-borne hemorrhagic fever |
Tick-borne hemorrhagic fever |
| Other umbilical cord complication, NEC |
Umbilical cord complication |
| Other unspecified derangement of medial meniscus, NEC |
Derangement of medial meniscus |
| Other uterine inertia, NEC |
Uterine inertia |
| Other venous complication of pregnancy or puerperium, NEC |
Venous complication of pregnancy and/or puerperium (disorder) |
| Other vomiting complicating pregnancy, NEC |
Vomiting of pregnancy |
| Otocolobus manul |
Felis manul |
| oto-palato-digitalt syndrom |
Otopalatodigital syndrome spectrum disorder |
| Otto's pelvis |
Intrapelvic protrusion of acetabulum |
| Otus asio |
Megascops asio (organism) |
| föråldrat begrepp |
Outdated component (foundation metadata concept) |
| överdos av natriumvalproat |
Valproate overdose |
| överdos av natriumvalproat, med oklar avsikt |
Valproate overdose |
| hypergranulerande operationssår under sekundär sårläkning |
Over-granulating secondary intention surgical wound (finding) |
| mer än 11 timmars nattfasta |
Overnight fasting period more than 11 hours |
| Ovis musimon |
Ovis aries |
| Ovula Nabothi |
Retention cyst |
| oxacillinnatrium 250 mg/5 ml, pulver till oral lösning |
Product containing precisely oxacillin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| poäng enligt Oxford knee score, version 1.0 |
Oxford Knee Score using revised scoring system (observable entity) |
| Oxidase |
Oxidase |
| Oxo-acid-lyase |
Oxo-acid-lyase |
| Oxybuprocaine 0.4% eye drops |
Oxybuprocaine only product |
| oxibuprokainhydroklorid 0,4 %, ögondroppar |
Oxybuprocaine only product |
| oxibuprokainhydroklorid 0,4 %, ögondroppar för engångsbruk |
Oxybuprocaine only product |
| oxibutynin 3,9 mg/dag, transdermalt system |
Product containing precisely oxybutynin 162 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
| oxibutyninhydroklorid 15 mg, tablett med modifierad frisättning |
Oxybutynin only product in oral dose form |
| oxibutyninhydroklorid 15 mg, depåtablett |
Oxybutynin only product in oral dose form |
| oxikodonhydroklorid 160 mg, tablett med modifierad frisättning |
Product containing only oxycodone in oral dose form (medicinal product form) |
| oxikodonhydroklorid 160 mg, depåtablett |
Product containing only oxycodone in oral dose form (medicinal product form) |
| Oxygenase |
Oxygenase |
| oximetazolinhydroklorid 0,025 %, näsdroppar |
Oxymetazoline hydrochloride 250 microgram/mL nasal solution |
| oximetazolinhydroklorid 0,05 %, ögondroppar |
Oxymetazoline hydrochloride 500 microgram/mL eye solution |
| oximetazolinhydroklorid 0,05 %, näsdroppar |
Oxymetazoline hydrochloride 500 microgram/mL nasal solution |
| oximorfon 10 mg, tablett med modifierad frisättning |
Oxymorphone only product in oral dose form |
| oximorfon 10 mg, depåtablett |
Oxymorphone only product in oral dose form |
| oximorfon 20 mg, tablett med modifierad frisättning |
Oxymorphone only product in oral dose form |
| oximorfon 20 mg, depåtablett |
Oxymorphone only product in oral dose form |
| oximorfon 40 mg, tablett med modifierad frisättning |
Oxymorphone only product in oral dose form |
| oximorfon 40 mg, depåtablett |
Oxymorphone only product in oral dose form |
| oximorfon 5 mg, tablett med modifierad frisättning |
Oxymorphone only product in oral dose form |
| oximorfon 5 mg, depåtablett |
Oxymorphone only product in oral dose form |
| Oxytocic preparation |
Medicinal product acting as oxytocic (product) |
| oxytocin 10 enheter/ml, infusionsvätska, lösning, flaska 1 ml |
Product containing precisely oxytocin 10 unit/1 milliliter conventional release solution for injection (clinical drug) |
| ostron, livsmedel |
Oyster (substance) |
| PegIntron 120 mikrogram pulver + sterilt vatten 0,5 ml, Redipen |
Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen |
| PegIntron 150 mikrogram pulver + sterilt vatten 0,5 ml, Redipen |
Interferon alfa-2b (as peginterferon alfa-2b) 150 microgram powder for solution for injection pen |
| PegIntron 50 mikrogram pulver + sterilt vatten 0,5 ml, Redipen |
Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen |
| PegIntron 80 mikrogram pulver + sterilt vatten 0,5 ml, Redipen |
Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen |
| PIE syndrome |
Simple pulmonary eosinophilia |
| Packing - action |
Insertion - action (qualifier value) |
| läkemedelseluerande stent innehållande paclitaxel 1 mikrogram/mm |
Paclitaxel 1 microgram/mm2 drug eluting stent (product) |
| Painful ejaculation |
Painful ejaculation |
| Palatoplasty |
Uvulopalatopharyngoplasty |
| pamidronatdinatrium 3 mg/ml, infusionskoncentrat, flaska 5 ml |
Product containing precisely disodium pamidronate 3 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Pancreas excision |
Pancreatectomy |
| pankrelipas, amylas:lipas, kapsel à 183,49 g |
Amylase and pancrelipase and triacylglycerol lipase only product |
| pankrelipas, amylas:lipas, kapsel à 184,84 mg |
Amylase and pancrelipase and triacylglycerol lipase only product |
| pankrelipas, amylas:lipas, kapsel à 210,33 mg |
Amylase and pancrelipase and triacylglycerol lipase only product |
| pankrelipas, amylas:lipas, 278,72 %, kapsel |
Amylase and pancrelipase and triacylglycerol lipase only product |
| pankrelipas, amylas:lipas, kapsel à 312,17 mg |
Amylase and pancrelipase and triacylglycerol lipase only product |
| pankrelipas, amylas:lipas, kapsel à 346,86 mg |
Amylase and pancrelipase and triacylglycerol lipase only product |
| pankrelipas, amylas:lipas, 4 500 enheter, kapsel |
Amylase and pancrelipase and triacylglycerol lipase only product |
| pankrelipas, amylas:lipas, 62,81 % |
Amylase and pancrelipase and triacylglycerol lipase only product |
| pankrelipas, amylas:lipas, 62,81 %, kapsel |
Amylase and pancrelipase and triacylglycerol lipase only product |
| pankrelipas, amylas:lipas, kapsel à 94,3 mg |
Amylase and pancrelipase and triacylglycerol lipase only product |
| Pantoprazole sodium 40mg injection |
Pantoprazole (as pantoprazole sodium) 40 mg powder for solution for injection vial |